Get Started
Tectonic Therapeutic, Inc.(TECX)
NASDAQ
$20.07
-1.02 (-4.84%)

Tectonic Therapeutic, Inc.(TECX)Company Profile & Business
NASDAQ

Company Profile

Business overview, scale, and footprint

Company NameTectonic Therapeutic, Inc.
Ticker SymbolTECX
ExchangeNGM
SectorHealthcare
IndustryBiotechnology
Employees60
CEODr. Alise S. Reicin M.D., Ph.D.
FoundedN/A
HeadquartersWatertown, MA, United States
CountryUnited States
Websitetectonictx.com
Next Earnings DateNov 5, 2026

Business Overview

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Insider Transactions

Open-market activity and option exercises

Insider Activity Summary

Insider trading activity for Tectonic Therapeutic, Inc. (TECX) between Mar 3, 2026 and Sep 30, 2026 consists of 11 total transactions. Among these, company executives and board members conducted 0 buys (totaling 0 shares) and 11 sells (totaling 22,420 shares). This activity resulted in a net change of -22,420 shares, reflecting net selling pressure with an estimated net sales value of $651,006.74.

11 insider transactions found. Showing 10 of 11 transactions.

Show:entries
Insider NameRelation to CompanyShares ChangedPriceTransaction Date
McNamara PeterChief Scientific Officer-536$23.04Sep 30, 2026
McNamara PeterChief Scientific Officer-43$36.52Aug 25, 2026
McNamara PeterChief Scientific Officer-43$35.00Aug 12, 2026
McNamara PeterChief Scientific Officer-172$35.00Jun 30, 2026
Ruddy Marcella K.Chief Medical Officer-1,065$30.00May 4, 2026
Ruddy Marcella K.Chief Medical Officer-1,000$31.05Apr 1, 2026
Ruddy Marcella K.Chief Medical Officer-10,000$30.00Mar 6, 2026
McNamara PeterChief Scientific Officer-6,047$30.00Mar 6, 2026
McNamara PeterChief Scientific Officer-215$35.00Mar 6, 2026
McNamara PeterChief Scientific Officer-1,650$25.00Mar 4, 2026
Page 1 of 2 (11 total transactions)

Explore More Analysis for TECX

Additional research, tools, and technical breakdowns

Stock Analyzer Report

Deep-dive automated research and stock rating report.

DCF Fair Value Calculator

Discounted cash flow model and intrinsic value projection.

AI Price Predictions

Multi-scenario price predictions and consensus targets.

Insider Activity Tracker

Track buying/selling behavior of corporate insiders.

Earnings Calendar

Track upcoming and historical corporate earnings reports.

Market Insights & Research

Read the latest analysis articles and expert research.

Latest TickZen Insights

All TickZen Insights →

Analysis Tools

→ Run TECX Stock Analyzer→ TECX DCF Fair Value Calculator→ TECX Algorithmic Stock Forecast→ Earnings Calendar→ Insider Activity Tracker

Insights & Resources

→ Latest Market Insights & Research→ Market News & Bulletins→ How Tickzen Forecasting Works→ Frequently Asked Questions